- Home
- OPTT vs ESLA Comparison
OPTT vs ESLA Comparison
Compare OPTT & ESLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OPTT
- ESLA
- Stock Information
- Founded
- OPTT 1984
- ESLA 2021
- Country
- OPTT United States
- ESLA United States
- Employees
- OPTT N/A
- ESLA N/A
- Industry
- OPTT Electric Utilities: Central
- ESLA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- OPTT Utilities
- ESLA Health Care
- Exchange
- OPTT Nasdaq
- ESLA Nasdaq
- Market Cap
- OPTT 40.4M
- ESLA 41.6M
- IPO Year
- OPTT 2007
- ESLA N/A
- Fundamental
- Price
- OPTT $0.35
- ESLA $1.12
- Analyst Decision
- OPTT
- ESLA
- Analyst Count
- OPTT 0
- ESLA 0
- Target Price
- OPTT N/A
- ESLA N/A
- AVG Volume (30 Days)
- OPTT 66.0M
- ESLA 59.0K
- Earning Date
- OPTT 12-16-2024
- ESLA 02-12-2025
- Dividend Yield
- OPTT N/A
- ESLA N/A
- EPS Growth
- OPTT N/A
- ESLA N/A
- EPS
- OPTT N/A
- ESLA N/A
- Revenue
- OPTT $7,083,000.00
- ESLA N/A
- Revenue This Year
- OPTT N/A
- ESLA N/A
- Revenue Next Year
- OPTT N/A
- ESLA N/A
- P/E Ratio
- OPTT N/A
- ESLA N/A
- Revenue Growth
- OPTT 82.74
- ESLA N/A
- 52 Week Low
- OPTT $0.12
- ESLA $0.63
- 52 Week High
- OPTT $0.82
- ESLA $3.23
- Technical
- Relative Strength Index (RSI)
- OPTT 51.87
- ESLA 56.94
- Support Level
- OPTT $0.27
- ESLA $1.03
- Resistance Level
- OPTT $0.39
- ESLA $1.39
- Average True Range (ATR)
- OPTT 0.07
- ESLA 0.19
- MACD
- OPTT -0.01
- ESLA -0.00
- Stochastic Oscillator
- OPTT 6.76
- ESLA 47.42
About OPTT Ocean Power Technologies Inc.
Ocean Power Technologies Inc provides intelligent maritime solutions and services that enable safer, cleaner, and more productive ocean operations for the defense and security, oil and gas, science and research, and offshore wind markets. It provides ocean data collection and reporting, marine power, offshore communications, and Maritime Domain Awareness System (MDAS) products, integrated solutions, and consulting services. The company offers its products and services to a wide range of customers, including those in government and offshore energy, oil and gas, construction, wind power, and other industries. The company has operations in North and South America, Europe, Asia and Australia.
About ESLA Estrella Immunopharma Inc.
Estrella Immunopharma Inc is a clinical-stage biopharmaceutical company developing CD19 and CD22-targeted ARTEMIS T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors. Estrella's mission is to harness the evolutionary power of the human immune system to transform the lives of patients fighting cancer and autoimmune diseases.